BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Report

SHIRE PHARMACEUTICALS

via THE WERNER GROUP

1st Quarter (Jan 1 - Mar 31) · 2008Posted Apr 7, 2008Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: SHIRE PHARMACEUTICALS
Description: pharmaceuticals research, development, and manufacture
Location: Pennsylvania · United States of America

Registrant

Firm: THE WERNER GROUP
Description: public policy consulting
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
LobbyistsMICHAEL WERNER

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

SHIRE PHARMACEUTICALS — Lobbying — Receipts Report